Company intelligence / Profile preview

Vividion Therapeutics

San Diego, California, United Statesvividion.com ↗
Ownership
Private
Employees
~250
Development stage
Preclinical
01

Overview

Vividion Therapeutics has advanced multiple novel small molecule drug candidates into clinical trials using its proprietary chemoproteomic platform. The company has demonstrated the ability to discover covalent allosteric inhibitors for challenging targets such as WRN helicase, with at least one program progressing rapidly into the clinic. Its pipeline includes highly selective therapeutics targeting previously inaccessible disease-causing proteins in oncology and immunology. The breadth of its pipeline spans several programs at various stages of development, though specific late-stage results are not detailed in public sources.[1][8]

Therapeutic areas
OncologyImmunologyNeurology
Modalities
Small molecules (covalent and allosteric inhibitors)[1][3][8]
Industry
Biotech
02

Drug pipeline

6 assets

VVD-133214

2

5 more assets in the full pipeline.

Request access →
03

Partnerships

Roche – collaboration on WRN inhibitor program[8]Celgene – $101M partnership focused on ubiquitin proteasome system-related drug discovery across oncology, inflammatory, neurodegenerative diseases[10]

Beyond the preview

Go deeper on Vividion Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vividion Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call